BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vinuesa A, Pomilio C, Gregosa A, Bentivegna M, Presa J, Bellotto M, Saravia F, Beauquis J. Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer's Disease. Front Neurosci 2021;15:653651. [PMID: 33967682 DOI: 10.3389/fnins.2021.653651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehdipour M, Daghigh-Kia H, Najafi A, Mehdipour Z, Mohammadi H. Protective effect of rosiglitazone on microscopic and oxidative stress parameters of ram sperm after freeze-thawing. Sci Rep 2022;12:13981. [PMID: 35978030 DOI: 10.1038/s41598-022-18298-2] [Reference Citation Analysis]
2 Alvariño R, Alfonso A, Pech-Puch D, Gegunde S, Rodríguez J, Vieytes MR, Jiménez C, Botana LM. Furanoditerpenes from Spongia (Spongia) tubulifera Display Mitochondrial-Mediated Neuroprotective Effects by Targeting Cyclophilin D. ACS Chem Neurosci 2022. [PMID: 35901231 DOI: 10.1021/acschemneuro.2c00208] [Reference Citation Analysis]
3 Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, Wang M, Yu CJ, Tang Y. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener 2022;17:40. [PMID: 35658903 DOI: 10.1186/s13024-022-00542-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fan YC, Chou CC, Bintoro BS, Chien KL, Bai CH. High sensitivity C-reactive protein and glycated hemoglobin levels as dominant predictors of all-cause dementia: a nationwide population-based cohort study. Immun Ageing 2022;19:10. [PMID: 35172860 DOI: 10.1186/s12979-022-00265-0] [Reference Citation Analysis]
5 Lupaescu A, Iavorschi M, Covasa M. The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease. Pharmaceutics 2022;14:235. [DOI: 10.3390/pharmaceutics14020235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Maluchenko NV, Feofanov AV, Studitsky VM. PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols. Int J Mol Sci 2021;22:11441. [PMID: 34768872 DOI: 10.3390/ijms222111441] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 García-Aviles JE, Méndez-Hernández R, Guzmán-Ruiz MA, Cruz M, Guerrero-Vargas NN, Velázquez-Moctezuma J, Hurtado-Alvarado G. Metabolic Disturbances Induced by Sleep Restriction as Potential Triggers for Alzheimer's Disease. Front Integr Neurosci 2021;15:722523. [PMID: 34539357 DOI: 10.3389/fnint.2021.722523] [Reference Citation Analysis]
8 Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment. Pharmaceuticals (Basel) 2021;14:890. [PMID: 34577590 DOI: 10.3390/ph14090890] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Vecchio I, Sorrentino L, Paoletti A, Marra R, Arbitrio M. The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease. J Cent Nerv Syst Dis 2021;13:11795735211029113. [PMID: 34285627 DOI: 10.1177/11795735211029113] [Cited by in F6Publishing: 8] [Reference Citation Analysis]